Here's why the Recce (ASX:RCE) share price is racing higher today

Here's why the Recce Pharmaceuticals Ltd (ASX:RCE) share price is pushing higher on Monday morning…

| More on:
high share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Recce Pharmaceuticals Ltd (ASX: RCE) share price is pushing higher on Monday morning.

At the time of writing, the synthetic anti-infectives focused biotechnology company's shares are up 3% to $1.01.

Why is the Recce share price pushing higher?

Investors have been buying Recce shares this morning after it announced the successful dual listing of its shares on the Frankfurt Stock Exchange in Germany. This will see the company's shares hit the Frankfurt bourse at the opening of trade at 8am central European time today.

According to the release, the dual listing was possible without many of the normal primary listing procedures. This means the company will benefit from a widening of its investor reach with minimal cost.

In addition, there was no associated capital raising for this listing or issuance of new securities. This was due to the company's strong existing financial position and the fact that it is listed and market-makable via the ASX.

Management commentary

Recce's Chairman, Dr. John Prendergast, appeared delighted with its dual listing.

He commented: "Dual-listing on the Frankfurt Stock Exchange is a wonderful new chapter in our global strategy. As the third largest stock exchange in the world, it sees the connection of EU biotech and overseas capital with the Company's New Classes of Synthetic Anti-Infectives development program."

The company's investor and corporate relations advisor in Europe, Deutsche Gesellschaft Für Wertpapieranalyse (DGWA), spoke very positively about the listing. It appears to believe Recce will be an attractive investment option for European investors.

DGWA's CEO, Stefan Müller, said: "DGWA are thrilled to be working with Recce in Europe. Investor interest in quality biotechnology companies is significant and increasing with the global anti-infective market expected to grow at a compound rate of over 30% to 2030 and anticipate this German listing will provide EU investors an opportunity to participate in that growth. We are confident Recce will be warmly welcomed among the European investment community and look forward to supporting their activity in the region over the time ahead."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Two men celebrate while another holds his head in his hands, after watching the race.
Share Gainers

Here are the top 10 ASX 200 shares today

Despite the RBA, investors were back to the races this Tuesday.

Read more »

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

These 3 ASX 200 shares have soared over 200% in a year!

And here's what to expect from the high-climbers in 2026.

Read more »

Happy work colleagues give each other a fist pump.
Share Gainers

Why Appen, Imricor, Qoria, and Xero shares are storming higher today

These shares are rising on Tuesday. But why?

Read more »

3 children standing on podiums wearing Olympic medals.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rather horrid start to the week's trading today.

Read more »

Three people with gold streamers celebrate good news.
Gold

How is this ASX gold stock rocketing 16% on Monday amid a tanking gold price?

Investors are shrugging off the sinking gold price and piling into this ASX gold stock on Monday. But why?

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why 4DMedical, DroneShield, New Hope, and Zip shares are pushing higher today

These shares are starting the week positively. But why?

Read more »

A man holds his head in his hands after seeing bad news on his laptop screen.
Share Gainers

These were the worst-performing ASX 200 shares in January

Investors were selling off these shares in January. But why?

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

These were the best-performing ASX 200 shares in January

Let's see why investors were bidding these shares higher during the month.

Read more »